This alternative pathway is dominant in both human CRPC cell lines and human PCa metastases, probably due to the deficiency of 17β-HSD3 and the over-activation of S5AR1, which prefers 4-AD over T, in prostate tumors [46,47]. The gene discussed is SRD5A1; the disease is posterior cortical atrophy.